The startup that wants to cure diseases and slow aging, with the help of AI | Semafor
Insilico Medicine used artificial intelligence to discover a potential new treatment for idiopathic pulmonary fibrosis.
Insilico's CEO believes that AI has the potential to create hyper-targeted drugs and extend human life by inhibiting cells associated with aging. [ more ]
The enigma of the rare genetic mutation that protects against cancer and heart attacks
Genetic mutation in Ecuadorian families with Laron Syndrome protects from cardiovascular diseases, potential for drug discovery for aging-related diseases. [ more ]
AI Is Transforming Drug Matching for Cancer, Rare Diseases | Entrepreneur
AI tools are revolutionizing drug discovery for rare diseases by repurposing existing medications, leading to cost-effective and efficient screening processes. [ more ]
The foundation behind Ozempic maker Novo Nordisk is funding an Nvidia-backed AI supercomputer project
Novo Nordisk is investing in an AI supercomputer through collaboration with Nvidia for drug discovery and other scientific advancements.
The Novo Nordisk Foundation's investment in the AI supercomputer is aimed at accelerating groundbreaking scientific discoveries and fostering collaboration between academia and industry. [ more ]
These Companies are Changing Biotech & Biopharma with AI in 2024
AI is revolutionizing the BioTech & BioPharma space by accelerating drug discovery and development processes.
Companies like Insilico Medicine and Exscientia are using AI platforms to design and optimize drug candidates, leading to faster timelines and more efficient drug development. [ more ]
InstaDeep, a decision-making AI company, has challenged the tech status quo by setting up shop in Tunis and operating in the complex domain of deep tech.
The company builds AI systems that can make decisions for businesses, with applications ranging from drug discovery to energy efficiency. [ more ]
1. AI is playing a crucial role in the fight against the COVID-19 pandemic, helping to analyze large amounts of data and develop solutions.
2. DeepMind's AlphaFold has shown promising results in predicting protein structures, a key step in understanding diseases and developing targeted therapies. [ more ]